Google's Venture Firm Taps Biotech Veteran in Life-Sciences Push

Schenkein was previously chief executive officer of Agios Pharmaceuticals, which he grew from a small closely held startup to a $3.1 billion biotechnology company

Comments

Popular posts from this blog